XTNT Xtant Medical Holdings Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: XTNT

Price (delayed)

$0.375

Market cap

$52.61M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.08

Enterprise value

$68.4M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 24

Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. ...

Highlights
XTNT's debt has surged by 69% since the previous quarter but it is down by 30% year-on-year
The company's EPS has shrunk by 167% YoY
XTNT's net income has dropped by 143% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.xtantmedical.com
Peers: STE SYK

Key stats

What are the main financial stats of XTNT

XTNT stock price

How has the Xtant Medical Holdings stock price performed over time
Intraday
5.93%
1 week
17.19%
1 month
15.42%
1 year
-42.22%
YTD
-52.17%
QTD
-10.93%

Financial performance

How have Xtant Medical Holdings's revenue and profit performed over time
Revenue
$109.53M
Gross profit
$65.05M
Operating income
-$10.5M
Net income
-$11.14M
Gross margin
59.4%
Net margin
-10.2%
XTNT's net margin has dropped by 183% year-on-year
XTNT's net income has dropped by 143% year-on-year
The company's gross profit fell by 15% YoY and by 14% QoQ
The revenue is down by 14% year-on-year and by 10% since the previous quarter

Price vs fundamentals

How does XTNT's price correlate with its fundamentals

Growth

What is Xtant Medical Holdings's growth rate over time

Valuation

What is Xtant Medical Holdings stock price valuation
XTNT P/E details
P/E
N/A
P/B
1.31
P/S
0.48
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.62
The company's EPS has shrunk by 167% YoY
XTNT's P/B is 41% below its 5-year quarterly average of 2.1 and 27% below its last 4 quarters average of 1.7
The equity has contracted by 18% from the previous quarter and by 17% YoY
The stock's price to sales (P/S) is 55% less than its 5-year quarterly average of 1.0 and 36% less than its last 4 quarters average of 0.7
The revenue is down by 14% year-on-year and by 10% since the previous quarter

Efficiency

How efficient is Xtant Medical Holdings business performance
Xtant Medical Holdings's ROIC has plunged by 200% from the previous quarter
Xtant Medical Holdings's ROA has plunged by 164% YoY
The ROE has plunged by 133% YoY

Dividends

What is XTNT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for XTNT.

Financial health

How did Xtant Medical Holdings financials performed over time
The total assets is 101% more than the total liabilities
Xtant Medical Holdings's quick ratio has decreased by 37% from the previous quarter and by 11% YoY
Xtant Medical Holdings's current ratio has decreased by 35% from the previous quarter and by 13% YoY
XTNT's debt is 35% smaller than its equity
The debt to equity has soared by 103% from the previous quarter but it has decreased by 14% YoY
XTNT's debt has surged by 69% since the previous quarter but it is down by 30% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.